Stifel Financial Corp. The company is headquartered in St. Louis, Missouri.
| Revenue (TTM) | $5.83B |
| Gross Profit (TTM) | $5.58B |
| EBITDA | — |
| Operating Margin | 21.80% |
| Return on Equity | 16.40% |
| Return on Assets | 2.25% |
| Revenue/Share (TTM) | $37.73 |
| Book Value | $35.15 |
| Price-to-Book | 2.07 |
| Price-to-Sales (TTM) | 1.82 |
| EV/Revenue | 2.202 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 50.60% |
| Quarterly Revenue Growth (YoY) | 12.70% |
| Shares Outstanding | $151.00M |
| Float | $145.53M |
| % Insiders | 3.17% |
| % Institutions | 93.38% |
Volatility is currently contracting
ST. LOUIS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for August 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel Financial announces the addition of three senior leaders to its Venture Banking business, further solidifying its presence across the East Coast.
MISSION Group (LSE:TMG) drew a bullish call from Stifel, which argued the marketing group's valuation overlooks a profit recovery driven by cost cuts and agency consolidation. The shares traded at 23.85p, up 4%, while the broker initiated coverage with a 'buy' rating and a 57p target, more than double the share price.
ST. LOUIS & LONDON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the appointments of Conor Daly and Jim Franz as Co-Heads of Leveraged Finance Sales in Europe, further strengthening the firm's global Fixed Income platform.
ST. LOUIS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for July 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel has reiterated its 'buy' rating on Faron Pharmaceuticals Limited (AIM:FARN), the Finnish biotech, maintaining a price target of €2.50 after the company's interims, which showed the company well-funded to push on with value-accretive work in the clinic. The stock closed at €0.48 on 25 August, implying upside of 418.1% to the target price.
ST. LOUIS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.34 per share, payable September 15, 2026, to shareholders of record at the close of business on September 1, 2026.
Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high as C$18 a share. The pitch: a pill-dispensing platform that's quietly solving one of healthcare's most expensive headaches.
Ron Kruszewski, Stifel chairman and ceo, says artificial intelligence will lead to productivity gains. He says financial advisers are still valuable and AI can help them.
Stifel Financial Corp. (SF) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SF and any ticker you trade — then tracks every position and per-strategy win rate.
